TWI813560B - 利用鹼性化劑的血液淨化 - Google Patents

利用鹼性化劑的血液淨化 Download PDF

Info

Publication number
TWI813560B
TWI813560B TW107108443A TW107108443A TWI813560B TW I813560 B TWI813560 B TW I813560B TW 107108443 A TW107108443 A TW 107108443A TW 107108443 A TW107108443 A TW 107108443A TW I813560 B TWI813560 B TW I813560B
Authority
TW
Taiwan
Prior art keywords
pharmaceutical composition
concentration
acid
urine
alkalinizing agent
Prior art date
Application number
TW107108443A
Other languages
English (en)
Chinese (zh)
Other versions
TW201838684A (zh
Inventor
阿部倫明
小柴生造
西岡浩一郎
川口和彦
山崎里美
寺中康行
Original Assignee
國立大學法人東北大學
日商日本化美化股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2017085741A external-priority patent/JP7578234B2/ja
Priority claimed from PCT/JP2017/032931 external-priority patent/WO2018193648A1/ja
Application filed by 國立大學法人東北大學, 日商日本化美化股份有限公司 filed Critical 國立大學法人東北大學
Publication of TW201838684A publication Critical patent/TW201838684A/zh
Application granted granted Critical
Publication of TWI813560B publication Critical patent/TWI813560B/zh

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
TW107108443A 2017-04-18 2018-03-13 利用鹼性化劑的血液淨化 TWI813560B (zh)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
JP2017082423 2017-04-18
JP2017-082423 2017-04-18
JP2017-085741 2017-04-24
JP2017085741A JP7578234B2 (ja) 2017-04-18 2017-04-24 アルカリ性化剤による血液浄化
JP2017103935 2017-05-25
JP2017-103935 2017-05-25
WOPCT/JP2017/032931 2017-09-12
PCT/JP2017/032931 WO2018193648A1 (ja) 2017-04-18 2017-09-12 アルカリ性化剤による血液浄化
??PCT/JP2017/032931 2017-09-12

Publications (2)

Publication Number Publication Date
TW201838684A TW201838684A (zh) 2018-11-01
TWI813560B true TWI813560B (zh) 2023-09-01

Family

ID=65033758

Family Applications (1)

Application Number Title Priority Date Filing Date
TW107108443A TWI813560B (zh) 2017-04-18 2018-03-13 利用鹼性化劑的血液淨化

Country Status (8)

Country Link
US (1) US20210121426A1 (enExample)
EP (1) EP3616721B1 (enExample)
JP (3) JP7219898B2 (enExample)
KR (1) KR102685723B1 (enExample)
CN (1) CN110799214A (enExample)
AU (1) AU2018254884C1 (enExample)
CA (1) CA3060154A1 (enExample)
TW (1) TWI813560B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6792848B2 (ja) * 2018-05-25 2020-12-02 国立大学法人 琉球大学 代謝改善剤
JPWO2020080499A1 (ja) 2018-10-17 2021-09-24 国立大学法人東北大学 新規医薬組成物
US20230293467A1 (en) * 2020-03-26 2023-09-21 Tohoku University Renal function protective agent
CN114794346A (zh) * 2022-04-25 2022-07-29 武汉汇天诚科技有限公司 一种复合固体饮料的配方

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007217366A (ja) * 2006-02-17 2007-08-30 Kirin Brewery Co Ltd 尿酸値降下用組成物
JP4087929B2 (ja) * 1997-08-27 2008-05-21 日清ペットフード株式会社 猫慢性腎不全治療用組成物及びその治療方法
CN101374416A (zh) * 2006-01-30 2009-02-25 环亚有限公司 逆转、防止、延迟或稳定软组织钙化的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60105619A (ja) * 1983-11-15 1985-06-11 Nippon Chemiphar Co Ltd 尿アルカリ化性食品組成物
JP2004131406A (ja) 2002-10-09 2004-04-30 Sekisui Chem Co Ltd 尿毒症性物質特異的認識ポリマー及び経口吸着剤
CA2687426A1 (en) * 2007-05-24 2008-11-27 Austin Health Prevention of acute kidney injury
BRPI0816066A2 (pt) * 2007-08-31 2017-05-02 C B Fleet Company Incorporated método de prevenção de nefrocalcinose
WO2010126146A1 (ja) * 2009-04-30 2010-11-04 Tanaka Noriaki 腎疾患重篤度を判定する方法又は装置若しくはその作動方法
JP6164719B2 (ja) 2009-10-27 2017-07-19 エイワイファーマ株式会社 白金含有薬剤投与による腎障害の軽減剤
CN105671120B (zh) 2010-07-05 2019-02-19 株式会社明治 具有肠内腐败物质的减少作用的双歧杆菌
MX357998B (es) * 2015-03-20 2018-07-11 Antonio Hernandez Miramontes Jorge Una mezcla de acidos carboxilicos, especificamente acido citrico, acido succinico, acido fumarico y acido malico para el tratamiento de pacientes con insuficiencia renal cronica, insuficiencia renal aguda, hepatopatias agudas o cronicas que cursen con hiperamonemia, enfermedades congenitas con alteraciones enzimaticas en el ciclo de la urea, asi como condiciones clínicas que cursen con balance nitrogenado negativo.
JPWO2020080499A1 (ja) * 2018-10-17 2021-09-24 国立大学法人東北大学 新規医薬組成物
WO2020080399A1 (ja) * 2018-10-17 2020-04-23 日本ケミファ株式会社 夜間多尿の治療又は予防剤
US20220202752A1 (en) * 2019-04-28 2022-06-30 Tohoku University Novel pharmaceutical composition

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4087929B2 (ja) * 1997-08-27 2008-05-21 日清ペットフード株式会社 猫慢性腎不全治療用組成物及びその治療方法
CN101374416A (zh) * 2006-01-30 2009-02-25 环亚有限公司 逆转、防止、延迟或稳定软组织钙化的方法
JP2007217366A (ja) * 2006-02-17 2007-08-30 Kirin Brewery Co Ltd 尿酸値降下用組成物

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
期刊 Igor Łoniewski1 and Donald E. Wesson, "Bicarbonate therapy for prevention of chronic kidney disease progression", Kidney International, 85, 無, 2014, 529–535. *
網路文獻 內衛藥製字第001727號許可證資料; *
網路文獻 衛署藥製字第041577號許可證資料; *

Also Published As

Publication number Publication date
TW201838684A (zh) 2018-11-01
JPWO2018193648A1 (ja) 2020-02-27
KR102685723B1 (ko) 2024-07-16
JP7756863B2 (ja) 2025-10-21
KR20190137147A (ko) 2019-12-10
CN110799214A (zh) 2020-02-14
JP7219898B2 (ja) 2023-02-09
EP3616721A1 (en) 2020-03-04
AU2018254884B2 (en) 2023-12-14
JPWO2018193752A1 (ja) 2020-03-05
EP3616721C0 (en) 2024-12-04
AU2018254884C1 (en) 2024-04-11
JP2023115271A (ja) 2023-08-18
US20210121426A1 (en) 2021-04-29
AU2018254884A1 (en) 2019-11-07
EP3616721B1 (en) 2024-12-04
CA3060154A1 (en) 2018-10-25
EP3616721A4 (en) 2020-12-30

Similar Documents

Publication Publication Date Title
TWI847827B (zh) 利用鹼性化劑的血液淨化
JP2023115271A (ja) アルカリ性化剤による血液浄化
JP7578243B2 (ja) アルカリ性化剤による血液浄化
WO2020080499A1 (ja) 新規医薬組成物
JP7482033B2 (ja) 夜間多尿の治療又は予防剤
WO2021193856A1 (ja) 腎機能保護剤
US20210369654A1 (en) Agent for improving quality of sleep
HK40079287A (en) Renal function protectant